Dynasty Wealth Management LLC Sells 118 Shares of STERIS plc (NYSE:STE)

Dynasty Wealth Management LLC cut its position in shares of STERIS plc (NYSE:STE) by 10.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,011 shares of the medical equipment provider’s stock after selling 118 shares during the period. Dynasty Wealth Management LLC’s holdings in STERIS were worth $208,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new position in shares of STERIS during the 3rd quarter valued at approximately $25,000. Human Investing LLC bought a new position in STERIS during the fourth quarter valued at $31,000. Central Pacific Bank Trust Division lifted its position in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares during the last quarter. Manchester Capital Management LLC lifted its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares during the last quarter. Finally, Quarry LP bought a new position in shares of STERIS in the 3rd quarter valued at about $67,000. 94.69% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on STE. Stephens reaffirmed an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, February 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Friday, November 8th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Stock Down 0.4 %

Shares of NYSE STE opened at $219.23 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The company has a market cap of $21.54 billion, a P/E ratio of 46.54 and a beta of 0.84. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The firm has a 50-day simple moving average of $214.76 and a two-hundred day simple moving average of $223.11.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.04%. STERIS’s dividend payout ratio (DPR) is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.